Related Experiment Video
Updated: Jun 3, 2026
Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
Published on: March 7, 2022
Targeted knockdown of canine KIT (stem cell factor receptor) using RNA interference
R C Elders1, A Holder, S J Baines
1Department of Veterinary Clinical Sciences, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire AL97TA, UK.
Abstract:
Canine mast cell tumours often express KIT mutations that result in constitutive activation of the c-kit receptor and which are associated with more aggressive disease. The aim of the current study was to determine whether small inhibitory RNA (SiRNA) molecules could specifically target canine KIT mRNA for knock-down. Canine beta-2 microglobulin (B2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and KIT sequences were cloned into the psiCHECK™-2 vector. SiRNA molecules, designed to target gene-specific sequences, were co-transfected with plasmid DNA into Chinese hamster ovary (CHO) cells. Renilla and firefly luciferase activity was measured using the Dual-GLO(®) Luciferase Assay (Promega). Using this reporter system, canine housekeeping gene-specific SiRNA molecules demonstrated knockdown of their targets (72.0% knockdown for B2M and 94.5% knockdown for GAPDH). An SiRNA molecule targeting exon 2 of canine KIT successfully knocked-down reporter gene expression of a KIT(26-407) construct (90.8% knockdown). An SiRNA molecule targeting a 48 base-pair in-tandem duplication mutation in KIT exon 11 selectively knocked down expression of the KIT(1569-1966mutant) construct (93.1% knockdown) but had no effect on the KIT(1569-1918wild-type) construct. The results show that RNA interference can be used to inhibit canine KIT mRNA expression and has the potential to selectively target the mutant version of KIT that is expressed by some malignant mast cells.
Insights
Small inhibitory RNA (siRNA) effectively reduced canine KIT mRNA, including specific mutant versions driving aggressive mast cell tumors. This RNA interference approach shows promise for targeted cancer therapy in dogs.
Area of Science:
- Veterinary Oncology
- Molecular Biology
- RNA Interference
Background:
- Canine mast cell tumors frequently harbor KIT mutations, leading to c-kit receptor overactivation and aggressive disease.
- Targeting these mutations offers a potential therapeutic strategy for canine cancer.
Purpose of the Study:
- To investigate the efficacy of small interfering RNA (siRNA) in specifically knocking down canine KIT mRNA.
- To assess the potential of siRNA to target both wild-type and mutant KIT sequences.
Main Methods:
- Canine KIT, beta-2 microglobulin (B2M), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) sequences were cloned into a reporter vector.
- siRNA molecules targeting specific canine genes were co-transfected into Chinese hamster ovary (CHO) cells.
- Reporter gene expression was quantified using a dual luciferase assay to measure knockdown efficiency.
Main Results:
- siRNA demonstrated significant knockdown of canine housekeeping genes B2M (72.0%) and GAPDH (94.5%).
- A KIT-specific siRNA achieved 90.8% knockdown of a KIT exon 2 reporter construct.
- An siRNA targeting a KIT exon 11 mutation selectively knocked down the mutant construct (93.1%) without affecting the wild-type construct.
Conclusions:
- RNA interference is a viable method for inhibiting canine KIT mRNA expression.
- siRNA technology can be developed to selectively target oncogenic KIT mutations in canine mast cell tumors.
More Related Videos
Related Concept Videos
02:15Experimental RNAi
01:16In-vitro Mutagenesis
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...